4.5 Article

Management of diabetic nephropathy: the role of sirtuin-1

Related references

Note: Only part of the references are listed.
Article Medicine, Research & Experimental

Formononetin attenuates kidney damage in type 2 diabetic rats

Manisha J. Oza et al.

LIFE SCIENCES (2019)

Article Biochemistry & Molecular Biology

Metformin overcomes high glucose-induced insulin resistance of podocytes by pleiotropic effects on SIRT1 and AMPK

Dorota Rogacka et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)

Article Urology & Nephrology

Increased podocyte Sirtuin-1 function attenuates diabetic kidney injury

Quan Hong et al.

KIDNEY INTERNATIONAL (2018)

Article Medicine, Research & Experimental

Aerobic Exercise Training Alleviates Renal Injury by Interfering with Mitochondrial Function in Type-1 Diabetic Mice

Lin-Xia Tang et al.

MEDICAL SCIENCE MONITOR (2018)

Article Medicine, General & Internal

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes

Christoph Wanner et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Article Medicine, Research & Experimental

Effect of Resveratrol Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion

Miriam Mendez-del Villar et al.

METABOLIC SYNDROME AND RELATED DISORDERS (2014)

Article Biochemistry & Molecular Biology

SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1

Michelle Pacholec et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Article Multidisciplinary Sciences

Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes

Jill C. Milne et al.

NATURE (2007)

Article Toxicology

Resveratrol-associated renal toxicity

JA Crowell et al.

TOXICOLOGICAL SCIENCES (2004)